Literature DB >> 18175143

Validity of observation interval for synchronous hepatic metastases of colorectal cancer: changes in hepatic and extrahepatic metastatic foci.

Yasuhiro Shimizu1, Kenzo Yasui, Tsuyoshi Sano, Takashi Hirai, Yukihide Kanemitsu, Koji Komori, Tomoyuki Kato.   

Abstract

BACKGROUND: In cases of synchronous colorectal hepatic metastases, the primary colorectal cancer maintains a strong influence on the metastases, so the possibility of occult hepatic and extrahepatic metastases must be kept in mind. Our treatment policy has been to reevaluate the metastases at an interval of 3 months after colorectal resection and determine treatment strategy. We examined the validity of observation interval for synchronous hepatic metastases.
MATERIALS AND METHODS: The treatment course was investigated for 36 patients with no extrahepatic lesion remnants at colorectal surgery and a simultaneously resectable liver (H1 group).
RESULTS: In the H1 group, eight patients underwent simultaneous colorectal and hepatic resections, while the treatment course for 28 patients was decided after an interval. Hepatic resection was not indicated in nine of the 28 patients during the interval. New lesions appeared during the interval in seven of 19 interval hepatic resection patients. In 16 (57%) of 28 interval patients, there was a change in the hepatic resection procedure or surgical indications.
CONCLUSION: Reevaluation after an observation interval allows accurate understanding of the number and location of hepatic metastases and is beneficial in determining candidates for surgery and in selecting treatment plan.

Entities:  

Mesh:

Year:  2008        PMID: 18175143     DOI: 10.1007/s00423-007-0258-2

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  17 in total

Review 1.  Surgical treatment for metastatic malignancies. Anatomical resection of liver metastasis: indications and outcomes.

Authors:  Kenzo Yasui; Yasuhiro Shimizu
Journal:  Int J Clin Oncol       Date:  2005-04       Impact factor: 3.402

2.  A new macroscopic classification predicts prognosis for patient with liver metastases from colorectal cancer.

Authors:  K Yasui; T Hirai; T Kato; A Torii; K Uesaka; T Morimoto; Y Kodera; Y Yamamura; T Kito; N Hamajima
Journal:  Ann Surg       Date:  1997-11       Impact factor: 12.969

3.  Hepatic resection for colorectal metastases: analysis of prognostic factors.

Authors:  S Ambiru; M Miyazaki; T Isono; H Ito; K Nakagawa; H Shimizu; K Kusashio; S Furuya; N Nakajima
Journal:  Dis Colon Rectum       Date:  1999-05       Impact factor: 4.585

4.  Combined colon and hepatic resection for synchronous colorectal liver metastases.

Authors:  S Lyass; G Zamir; I Matot; D Goitein; A Eid; O Jurim
Journal:  J Surg Oncol       Date:  2001-09       Impact factor: 3.454

5.  Treatment strategy for synchronous metastases of colorectal cancer: is hepatic resection after an observation interval appropriate?

Authors:  Yasuhiro Shimizu; Kenzo Yasui; Tsuyoshi Sano; Takashi Hirai; Yukihide Kanemitsu; Koji Komori; Tomoyuki Kato
Journal:  Langenbecks Arch Surg       Date:  2007-02-09       Impact factor: 3.445

6.  Interval hepatic resection of colorectal metastases improves patient selection.

Authors:  L A Lambert; T A Colacchio; R J Barth
Journal:  Arch Surg       Date:  2000-04

7.  Concurrent vs. staged colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases.

Authors:  Heidi K Chua; Karl Sondenaa; Gregory G Tsiotos; Dirk R Larson; Bruce G Wolff; David M Nagorney
Journal:  Dis Colon Rectum       Date:  2004-08       Impact factor: 4.585

8.  Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases.

Authors:  Kuniya Tanaka; Hiroshi Shimada; Kenichi Matsuo; Yasuhiko Nagano; Itaru Endo; Hitoshi Sekido; Shinji Togo
Journal:  Surgery       Date:  2004-09       Impact factor: 3.982

9.  Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis.

Authors:  Robert Martin; Philip Paty; Yuman Fong; Andrew Grace; Alfred Cohen; Ronald DeMatteo; William Jarnagin; Leslie Blumgart
Journal:  J Am Coll Surg       Date:  2003-08       Impact factor: 6.113

10.  Surgery for synchronous hepatic metastases of colorectal cancer.

Authors:  H Bismuth; D Castaing; O Traynor
Journal:  Scand J Gastroenterol Suppl       Date:  1988
View more
  4 in total

1.  Outcomes after hepatic and pulmonary metastasectomies compared with pulmonary metastasectomy alone in patients with colorectal cancer metastasis to liver and lungs.

Authors:  Norifumi Hattori; Yukihide Kanemitsu; Koji Komori; Yasuhiro Shimizu; Tsuyoshi Sano; Yoshiki Senda; Tetsuya Mitsudomi; Takayuki Fukui
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

Review 2.  New Frontiers in Management of Early and Advanced Rectal Cancer.

Authors:  Jordan R Wlodarczyk; Sang W Lee
Journal:  Cancers (Basel)       Date:  2022-02-14       Impact factor: 6.639

3.  Pathological complete response of colorectal liver metastases following chemotherapy with S-1 and oxaliplatin (SOX) in combination with bevacizumab: A case report.

Authors:  Tomoya Yokota; Tsuyoshi Sano; Yasuhiro Shimizu; Daisuke Takahari; Yoshiki Senda; Masahiro Shimura; Takashi Ura; Kohei Shitara; Yuji Nimura; Yasushi Yatabe; Kei Muro
Journal:  Oncol Lett       Date:  2011-01-21       Impact factor: 2.967

Review 4.  Is precision medicine for colorectal liver metastases still a utopia? New perspectives by modern biomarkers, radiomics, and artificial intelligence.

Authors:  Luca Viganò; Visala S Jayakody Arachchige; Francesco Fiz
Journal:  World J Gastroenterol       Date:  2022-02-14       Impact factor: 5.374

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.